Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

Association between natural immunity and risk of SARS-CoV-2 reinfection and COVID-19 hospitalization

4 Apr 2022
mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

mRNA-1273 and BNT162b2 COVID-19 vaccines induce slightly different immune responses

4 Apr 2022
The effect of COVID-19 on the lung function of young adults

The effect of COVID-19 on the lung function of young adults

3 Apr 2022
Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

Researchers explore a novel method to isolate monoclonal antibodies from COVID-19 convalescents infected with SARS-CoV-2 variants

1 Apr 2022
Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

Study finds COVID-19 convalescent children had more robust humoral immune responses to SARS-CoV-2 than convalescent adults

1 Apr 2022
Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

Study explores molecular mechanisms underlying SARS-CoV-2 infection of macrophages and the induction of pro-inflammatory cytokines

1 Apr 2022
Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

Study identifies a new class of monoclonal antibodies that neutralize both alpha and beta coronaviruses

1 Apr 2022
No evidence of SARS-CoV-2 in the U.K.'s wild deer population

No evidence of SARS-CoV-2 in the U.K.'s wild deer population

31 Mar 2022
NIH program provides a real-time risk assessment of variants of SARS-CoV-2

NIH program provides a real-time risk assessment of variants of SARS-CoV-2

31 Mar 2022
Therapeutic antibodies against filoviruses including Ebola and Marburg

Therapeutic antibodies against filoviruses including Ebola and Marburg

31 Mar 2022
Potential new approach could make Japanese encephalitis vaccine more affordable

Potential new approach could make Japanese encephalitis vaccine more affordable

31 Mar 2022
The mucosal antibody response to SARS-CoV-2

The mucosal antibody response to SARS-CoV-2

31 Mar 2022
UIC researchers projected to receive $22 million to study long COVID-19

UIC researchers projected to receive $22 million to study long COVID-19

31 Mar 2022
Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

Risk of breakthrough infections by SARS-CoV-2 Omicron and Delta variants in fully vaccinated adults

31 Mar 2022
Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

Mosaic-8 RBD-nanoparticles show promise as a vaccine candidate for SARS-CoV-2 and potential sarbecoviruses spillovers

31 Mar 2022
Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

Messenger ribonucleic acid boosters shown to be effective against Omicron infections in mice

31 Mar 2022
Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

Common coronavirus infections don't generate antibodies that effectively cross-react with SARS-CoV-2

30 Mar 2022
SARS-CoV-2 and pandemic chilblains

SARS-CoV-2 and pandemic chilblains

30 Mar 2022
Research provides a roadmap for new therapies to treat chorioamnionitis

Research provides a roadmap for new therapies to treat chorioamnionitis

30 Mar 2022
ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

ACE2 decoy receptor with robust neutralization against Omicron subvariants shows therapeutic potential

30 Mar 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback